The report gives the overview of Primary progressive multiple sclerosis disease indication in detail, highlights the PPMS epidemiology in the key geographies, elaborates on the drugs prescribed and expected to be prescribed in PPMS and covers the detailed market sizing drug wise and country wise in value sales and patient numbers along with forecast. The report elaborates on the Primary Progressive Multiple Sclerosis disease indication detailing the definition, causes, profile of a PPMS patient, Symptoms of PPMS patient, and disease progression in a PPMS patient.

The report further highlights the multiple methods through which the patient can be diagnosed for PPMS. The next part of the report consists of PPMS epidemiology and prevalence in the key geographies across the globe like US, UK, Germany, Italy, France, Spain, Japan etc. The epidemiology for PPMS indication across key geographies has been forecasted till 2024 as well in the report. The next part of the report highlights the importance of factors influencing the physician prescription decisions in PPMS like efficacy factors, Tolerability factors, Monitoring requirements and pricing factors.

The report further details the drugs prescribed or expected to be prescribed in PPMS by the physicians in terms of details about the formulation, molecule, mode of administration and MoA of the drugs, their patent and trial details and the expected impact of drug in the PPMS market. The report further details the drug attribute analysis drug wise on each parameter considered important in the prescription of PPMS drugs. The report also covers the other products which are currently in the pipeline for PPMS and other progressive forms of MS. The final part of the report gives a detailed overview of PPMS market sizing drug wise and geography wise both in terms of value sales and patient numbers. The drugs have been forecasted till 2030 both for value sales and patient numbers geography wise.

Price: USD 10000

*Special Offer Price: USD 5000

For Table of content Click Here

For any queries regarding the report please email at sales@pharmascroll.com and we would get back to you in the shortest possible time.